Literature DB >> 17369047

Gap junctional control of glial glutamate transporter expression.

Maciej Figiel1, Claudia Allritz, Claudia Lehmann, Jürgen Engele.   

Abstract

The uptake of glutamate into astroglia is the predominant mechanism to terminate glutamatergic neurotransmission and to prevent neurotoxic extracellular glutamate concentrations. Here, we show that uncoupling cultured cortical astrocytes with the gap junction blocker, propofol, or the Cx43 mimetic peptide, Gap27, inhibits the expression of GLT-1, the major glutamate transporter subtype in the cortex. The dependence of GLT-1 expression on gap junctions was further confirmed by the use of astrocytes in which either the expression of Cx43, the major astrocytic gap junction protein, was inhibited by RNA interference or which were derived from animals carrying an astrocyte-specific deletion of the Cx43 gene. In both cases, reduced astrocytic coupling was associated with a pronounced decline in GLT-1 expression. Finally, a luciferase reporter gene assay demonstrated that blockade of gap junctions/connexins suppressed transcriptional activity of GLT-1 promoter. These observations unravel a previously unrecognized role of gap junctions in the control of glial glutamate transport.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17369047     DOI: 10.1016/j.mcn.2007.02.009

Source DB:  PubMed          Journal:  Mol Cell Neurosci        ISSN: 1044-7431            Impact factor:   4.314


  17 in total

1.  The rates of postmortem proteolysis of glutamate transporters differ dramatically between cells and between transporter subtypes.

Authors:  Yuchuan Li; Yun Zhou; Niels Christian Danbolt
Journal:  J Histochem Cytochem       Date:  2012-08-02       Impact factor: 2.479

Review 2.  Gap junction channels as potential targets for the treatment of major depressive disorder.

Authors:  Qian Ren; Zhen-Zhen Wang; Shi-Feng Chu; Cong-Yuan Xia; Nai-Hong Chen
Journal:  Psychopharmacology (Berl)       Date:  2017-11-25       Impact factor: 4.530

3.  Neuroinflammation leads to region-dependent alterations in astrocyte gap junction communication and hemichannel activity.

Authors:  Nikolay Karpuk; Maria Burkovetskaya; Teresa Fritz; Amanda Angle; Tammy Kielian
Journal:  J Neurosci       Date:  2011-01-12       Impact factor: 6.167

4.  A novel serum free primary astrocyte culture method that mimic quiescent astrocyte phenotype.

Authors:  Jude Prah; Ali Winters; Kiran Chaudhari; Jessica Hersh; Ran Liu; Shao-Hua Yang
Journal:  J Neurosci Methods       Date:  2019-03-20       Impact factor: 2.390

5.  Reduced connexin 43 immunolabeling in the orbitofrontal cortex in alcohol dependence and depression.

Authors:  José Javier Miguel-Hidalgo; Barbara A Wilson; Syed Hussain; Ashish Meshram; Grazyna Rajkowska; Craig A Stockmeier
Journal:  J Psychiatr Res       Date:  2014-04-16       Impact factor: 4.791

Review 6.  Modulation of brain hemichannels and gap junction channels by pro-inflammatory agents and their possible role in neurodegeneration.

Authors:  Juan A Orellana; Pablo J Sáez; Kenji F Shoji; Kurt A Schalper; Nicolás Palacios-Prado; Victoria Velarde; Christian Giaume; Michael V L Bennett; Juan C Sáez
Journal:  Antioxid Redox Signal       Date:  2009-02       Impact factor: 8.401

Review 7.  Inflammation, Glutamate, and Glia: A Trio of Trouble in Mood Disorders.

Authors:  Ebrahim Haroon; Andrew H Miller; Gerard Sanacora
Journal:  Neuropsychopharmacology       Date:  2016-09-15       Impact factor: 7.853

8.  Astroglial Wiring is Adding Complexity to Neuroglial Networking.

Authors:  Christian Giaume
Journal:  Front Neuroenergetics       Date:  2010-09-20

9.  Altered expression of glutamate signaling, growth factor, and glia genes in the locus coeruleus of patients with major depression.

Authors:  R Bernard; I A Kerman; R C Thompson; E G Jones; W E Bunney; J D Barchas; A F Schatzberg; R M Myers; H Akil; S J Watson
Journal:  Mol Psychiatry       Date:  2010-04-13       Impact factor: 15.992

Review 10.  Astrocyte metabolism and signaling during brain ischemia.

Authors:  David J Rossi; James D Brady; Claudia Mohr
Journal:  Nat Neurosci       Date:  2007-11       Impact factor: 24.884

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.